DexCom Inc (NAS:DXCM)
$ 129.71 3.74 (2.97%) Market Cap: 51.58 Bil Enterprise Value: 49.79 Bil PE Ratio: 83.68 PB Ratio: 22.88 GF Score: 89/100

Q2 2020 DexCom Inc Earnings Call Transcript

Jul 28, 2020 / 08:30PM GMT
Release Date Price: $104.45 (-1.33%)
Operator

Welcome to the Dexcom Second Quarter 2020 Earnings Release Conference Call. My name is Adrienne, and I'll be your operator for this call. (Operator Instructions) Please note, this conference call is being recorded. I'll now turn the call over to Sean Christensen. Sean, you may begin.

Sean Christensen
DexCom, Inc. - Senior IR Manager

Thank you, operator, and welcome to Dexcom's Second Quarter 2020 Earnings Call. Our agenda begins with Kevin Sayer, Dexcom's Chairman, President and CEO, who will provide a summary of the quarter; followed by a financial review and outlook from Quentin Blackford, our COO and CFO; and then a strategic update from Steve Pacelli, our Executive Vice President of Strategy and Corporate Development. Following our prepared remarks, we will open the call up for your questions. (Operator Instructions)

Please note there are also slides available related to our second quarter performance on the Dexcom Investor Relations website on the Events and Presentations page. With that, let's review our safe harbor statement.

Some of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot